Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer

M Wachowska, A Muchowicz, M Firczuk, M Gabrysiak… - Molecules, 2011 - mdpi.com
Aminolevulinic acid (ALA) is an endogenous metabolite normally formed in the mitochondria
from succinyl-CoA and glycine. Conjugation of eight ALA molecules yields protoporphyrin IX …

Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology

SR Wiegell, HC Wulf, RM Szeimies… - Journal of the …, 2012 - Wiley Online Library
Photodynamic therapy (PDT) is an attractive therapy for non‐melanoma skin cancers
including actinic keratoses (AKs) because it allows treatment of large areas; it has a high …

Photodynamic therapy by in situ nonlinear photon conversion

AV Kachynski, A Pliss, AN Kuzmin, TY Ohulchanskyy… - Nature …, 2014 - nature.com
In photodynamic therapy, light is absorbed by a therapy agent (photosensitizer) to generate
reactive oxygen, which then locally kills diseased cells. Here, we report a new form of …

Photodynamic therapy for skin cancer: How to enhance drug penetration?

M Champeau, S Vignoud, L Mortier… - Journal of Photochemistry …, 2019 - Elsevier
Photodynamic therapy (PDT) induced by protoporphyrin IX (PpIX) has been widely used in
dermatological practices such as treatment of skin cancers. Clearance rate depends on …

Photodynamic therapy and the biophysics of the tumor microenvironment

AJ Sorrin, M Kemal Ruhi, NA Ferlic… - Photochemistry and …, 2020 - Wiley Online Library
Targeting the tumor microenvironment (TME) provides opportunities to modulate tumor
physiology, enhance the delivery of therapeutic agents, impact immune response and …

Gain with no pain? Pain management in dermatological photodynamic therapy

B Wang, L Shi, YF Zhang, Q Zhou… - British Journal of …, 2017 - academic.oup.com
Pain during photodynamic therapy (PDT) is the main limiting adverse effect in its use in
dermatology. Given its multifactorial nature, we reviewed both intrinsic and extrinsic factors …

Weather conditions and daylight‐mediated photodynamic therapy: protoporphyrin IX‐weighted daylight doses measured in six geographical locations

SR Wiegell, S Fabricius, J Heydenreich… - British Journal of …, 2013 - academic.oup.com
Background Photodynamic therapy (PDT) is an attractive therapy for nonmelanoma skin
cancers and actinic keratoses (AKs). Daylight‐mediated methyl aminolaevulinate PDT …

Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy

MJP Gerritsen, T Smits, MM Kleinpenning… - Dermatology, 2009 - karger.com
The response rates of photodynamic therapy (PDT) vary widely. Limited uptake of topically
applied 5-aminolaevulinic acid (ALA), or its methyl ester (MAL), and suboptimal production …

Photodynamic therapy for actinic keratosis in organ transplant patients

N Basset‐Seguin, K Baumann Conzett… - Journal of the …, 2013 - Wiley Online Library
Background The incidence of actinic keratoses (AK) and non‐melanoma skin cancer
(NMSC) in organ transplant recipients (OTRs) is significantly higher than in …

Photoactivatable carbon nanodots for cancer therapy

P Juzenas, A Kleinauskas, P George Luo… - Applied Physics …, 2013 - pubs.aip.org
In this study, we describe a photocatalytic system based on spherical fluorescent carbon-
core nanoparticles (nanodots) that can be activated with ultraviolet radiation. The carbon …